Bradley Vince

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

Lawrence P. Carter, Jack E. Henningfield, Y Grace Wang et al. · Journal of Psychopharmacology · 2018 · 183 citations · Full text

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder

Sharon Walsh, Sandra D. Comer, Michelle R. Lofwall et al. · JAMA Psychiatry · 2017 · 75 citations · Full text

Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder

Azmi Nasser, Mark K. Greenwald, Bradley Vince et al. · Journal of Clinical Psychopharmacology · 2015 · 74 citations · Full text

A phase 1 study investigating DX-2930 in healthy subjects

Yung Chyung, Bradley Vince, Ryan Iarrobino et al. · Annals of Allergy Asthma & Immunology · 2014 · 57 citations · Full text

Psychomotor Functioning and Alertness with Guanfacine Extended Release in Subjects with Attention-Deficit/Hyperactivity Disorder

Scott H. Kollins, Frank A. López, Bradley Vince et al. · Journal of Child and Adolescent Psychopharmacology · 2011 · 52 citations

Sleep Disorders, Neuropsychology, Adhd Symptoms +27